About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Click here to read more

Post navigation

Change of Company Name and ASX Code

Avecho investor update – webinar recording

Related Posts

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

January 20, 2016

Investor Presentation April 2018

April 17, 2018

Phosphagenics Full Year Financial Results

February 28, 2017

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.